Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

159 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long non-coding RNAs and exosomal lncRNAs: Potential functions in lung cancer progression, drug resistance and tumor microenvironment remodeling.
Entezari M, Ghanbarirad M, Taheriazam A, Sadrkhanloo M, Zabolian A, Goharrizi MASB, Hushmandi K, Aref AR, Ashrafizadeh M, Zarrabi A, Nabavi N, Rabiee N, Hashemi M, Samarghandian S. Entezari M, et al. Among authors: nabavi n. Biomed Pharmacother. 2022 Jun;150:112963. doi: 10.1016/j.biopha.2022.112963. Epub 2022 Apr 22. Biomed Pharmacother. 2022. PMID: 35468579 Free article. Review.
Long non-coding RNAs in the doxorubicin resistance of cancer cells.
Ashrafizaveh S, Ashrafizadeh M, Zarrabi A, Husmandi K, Zabolian A, Shahinozzaman M, Aref AR, Hamblin MR, Nabavi N, Crea F, Wang Y, Ahn KS. Ashrafizaveh S, et al. Among authors: nabavi n. Cancer Lett. 2021 Jun 28;508:104-114. doi: 10.1016/j.canlet.2021.03.018. Epub 2021 Mar 22. Cancer Lett. 2021. PMID: 33766750 Review.
The long and short non-coding RNAs modulating EZH2 signaling in cancer.
Mirzaei S, Gholami MH, Hushmandi K, Hashemi F, Zabolian A, Canadas I, Zarrabi A, Nabavi N, Aref AR, Crea F, Wang Y, Ashrafizadeh M, Kumar AP. Mirzaei S, et al. Among authors: nabavi n. J Hematol Oncol. 2022 Mar 2;15(1):18. doi: 10.1186/s13045-022-01235-1. J Hematol Oncol. 2022. PMID: 35236381 Free PMC article. Review.
Pre-clinical investigation of STAT3 pathway in bladder cancer: Paving the way for clinical translation.
Mirzaei S, Gholami MH, Mahabady MK, Nabavi N, Zabolian A, Banihashemi SM, Haddadi A, Entezari M, Hushmandi K, Makvandi P, Samarghandian S, Zarrabi A, Ashrafizadeh M, Khan H. Mirzaei S, et al. Among authors: nabavi n. Biomed Pharmacother. 2021 Jan;133:111077. doi: 10.1016/j.biopha.2020.111077. Epub 2020 Dec 4. Biomed Pharmacother. 2021. PMID: 33378975 Free article. Review.
Nrf2 signaling pathway in cisplatin chemotherapy: Potential involvement in organ protection and chemoresistance.
Mirzaei S, Mohammadi AT, Gholami MH, Hashemi F, Zarrabi A, Zabolian A, Hushmandi K, Makvandi P, Samec M, Liskova A, Kubatka P, Nabavi N, Aref AR, Ashrafizadeh M, Khan H, Najafi M. Mirzaei S, et al. Among authors: nabavi n. Pharmacol Res. 2021 May;167:105575. doi: 10.1016/j.phrs.2021.105575. Epub 2021 Mar 24. Pharmacol Res. 2021. PMID: 33771701 Review.
Interplay between SOX9 transcription factor and microRNAs in cancer.
Ashrafizadeh M, Zarrabi A, Orouei S, Zabolian A, Saleki H, Azami N, Bejandi AK, Mirzaei S, Janaghard MN, Hushmandi K, Nabavi N, Baradaran B, Kumar AP, Makvandi P, Samarghandian S, Khan H, Hamblin MR. Ashrafizadeh M, et al. Among authors: nabavi n. Int J Biol Macromol. 2021 Jul 31;183:681-694. doi: 10.1016/j.ijbiomac.2021.04.185. Epub 2021 May 3. Int J Biol Macromol. 2021. PMID: 33957202 Review.
Correction: The long and short non-coding RNAs modulating EZH2 signaling in cancer.
Mirzaei S, Gholami MH, Hushmandi K, Hashemi F, Zabolian A, Canadas I, Zarrabi A, Nabavi N, Aref AR, Crea F, Wang Y, Ashrafizadeh M, Kumar AP. Mirzaei S, et al. Among authors: nabavi n. J Hematol Oncol. 2022 May 6;15(1):50. doi: 10.1186/s13045-022-01276-6. J Hematol Oncol. 2022. PMID: 35524266 Free PMC article. No abstract available.
Molecular Landscape of LncRNAs in Prostate Cancer: A focus on pathways and therapeutic targets for intervention.
Mirzaei S, Paskeh MDA, Okina E, Gholami MH, Hushmandi K, Hashemi M, Kalu A, Zarrabi A, Nabavi N, Rabiee N, Sharifi E, Karimi-Maleh H, Ashrafizadeh M, Kumar AP, Wang Y. Mirzaei S, et al. Among authors: nabavi n. J Exp Clin Cancer Res. 2022 Jul 1;41(1):214. doi: 10.1186/s13046-022-02406-1. J Exp Clin Cancer Res. 2022. PMID: 35773731 Free PMC article. Review.
159 results